Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee

11Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are many difficulties in undertaking independent clinical research without support from the pharmaceutical industry. In this retrospective observational study, some design characteristics, the clinical trial public register and the publication rate of noncommercial clinical trials were compared to those of commercial clinical trials. A total of 809 applications of drug-evaluation clinical trials were submitted from May 2004 to May 2009 to the research ethics committee of a tertiary hospital, and 16.3% of trials were noncommercial. They were mainly phase IV, multicentre national, and unmasked controlled trials, compared to the commercial trials that were mainly phase II or III, multicentre international, and double-blind masked trials. The commercial trials were registered and published more often than noncommercial trials. More funding for noncommercial research is still needed. The results of the research, commercial or noncommercial, should be disseminated in order not to compromise either its scientific or its social value.

Cite

CITATION STYLE

APA

Fuentes Camps, I., Rodríguez, A., & Agustí, A. (2018). Non-commercial vs. commercial clinical trials: a retrospective study of the applications submitted to a research ethics committee. British Journal of Clinical Pharmacology, 84(6), 1384–1388. https://doi.org/10.1111/bcp.13555

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free